Critically ill patients with severe infections related to Geotrichum species: A French retrospective multicentre study.


Journal

Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 25 11 2021
received: 27 10 2021
accepted: 26 11 2021
pubmed: 3 12 2021
medline: 4 2 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Geotrichum spp can be responsible for severe infections in immunocompromised patients. We aim to describe Geotrichum-related infections in the ICU and to assess risk factors of mortality. Retrospective multicentre study, conducted in 14 French ICUs between 2002 and 2018, including critically ill adult patients with proven or probable infection related to Geotrichum species. Data were obtained from the medical charts. Thirty-six patients, median age 60 years IQR [53; 66] were included. Most of the patients had haematological malignancies (78%). The reason for ICU admission was shock in half of the patients (n = 19, 53%) and respiratory failure in thirteen patients (36%). Median SOFA score was 8.5 IQR [7; 15]. Time between ICU admission and fungal diagnosis was 2.5 days [-1; 4]. Infection was disseminated in 27 (75%) patients with positive blood cultures in 25 patients (69%). Thirty patients (83%) received curative antifungal treatment in the ICU, in a median time of 1 day [0;1] after ICU admission. Twenty-four patients (67%) died in the ICU and hospital mortality rate was 69%. The number and extent of organ failures, as represented by SOFA score, were associated with mortality. This study demonstrates poor outcome in critically ill patients with Geotrichum-related infections, which encourages a high level of suspicion.

Identifiants

pubmed: 34856032
doi: 10.1111/myc.13407
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-232

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Durán Graeff L, Seidel D, Vehreschild MJGT, et al. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses. 2017;60(4):273-279.
Hoog S, Smith M. Ribosomal gene phylogeny and species delimitation in Geotrichum and its teleomorph. Stud Mycol. 2004;50:489-515.
Chen SCA, Perfect J, Colombo AL, et al. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2021;S1473 (21):203-206.
Vaux S, Criscuolo A, Desnos-Ollivier M, et al. Multicenter outbreak of infections by Saprochaete clavata, an unrecognized opportunistic fungal pathogen. MBio. 2014;5(6).
Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43(4):1818-1828.
Mazzocato S, Marchionni E, Fothergill AW, et al. Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature. Infection. 2015;43(2):211-215.
Arendrup MC, Boekhout T, Akova M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl 3):76-98.
Martino R, Salavert M, Parody R, et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis. 2004;38(3):335-341.
Ulu-Kilic A, Atalay MA, Metan G, et al. Saprochaete capitata as an emerging fungus among patients with haematological malignencies. Mycoses. 2015;58(8):491-497.
Buchta V, Bolehovská R, Hovorková E, Cornely OA, Seidel D, Žák P. Saprochaete clavata invasive infections - a new threat to hematological-oncological patients. Front Microbiol. 2019;10:2196.
Cornely OA, Gachot B, Akan H, et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61(3):324-331.
Pérez-Sanchez I, Anguita J, Martín-Rabadan P, et al. Blastoschizomyces capitatus infection in acute leukemia patients. Leuk Lymphoma. 2000;39(1-2):209-212.
Hajar Z, Medawar W, Rizk N. Saprochaete capitata (Geotrichum capitatum), an emerging fungal infection in kidney transplant recipients. J Mycol Med. 2018;28(2):387-389.
Cavanna C, Lallitto F, Mangione F, Tamarozzi F, Marone P, Ceriana P. Fungemia due to Saprochaete capitata in a non-neutropenic patient hospitalized in an intensive care unit after cardiac surgery. J Mycol Med. 2017;27(2):281-284.
Nedel WL, Moraes VD, Falci DR, Pasqualotto AC. Geotrichum capitatum fungaemia: an unusual pathogen in critically-ill-related infections. Anaesth Intensive Care. 2013;41(5):685-687.
Ersoz G, Otag F, Erturan Z, et al. An outbreak of Dipodascus capitatus infection in the ICU: three case reports and review of the literature. Jpn J Infect Dis. 2004;57(6):248-252.
Chittick P, Palavecino EL, Delashmitt B, Evans J, Peacock JE. Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrob Agents Chemother. 2009;53(12):5306-5307.
Schuermans C, van Bergen M, Coorevits L, et al. Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Med Mycol. 2011;49(4):414-418.
Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367-1376.
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710.
Bansal N, Devarajan V, Ghafur KA, Sethuraman N, Sree VL. Breakthrough Saprochaete Capitata infections among patients with hematological malignancies. Leuk Lymphoma. 2018;59(7):1762-1763.
Cetintepe T, Cetintepe L, Solmaz S, et al. Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit. Support Care Cancer. 2021;29(7):4089-4094.
Hourmant Y, Mailloux A, Valade S, Lemiale V, Azoulay E, Darmon M. Impact of early ICU admission on outcome of critically ill and critically ill cancer patients: A systematic review and meta-analysis. J Crit Care. 2021;61:82-88.
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1-e50.

Auteurs

Sandrine Valade (S)

AP-HP, Hôpital Saint-Louis, Medical ICU, Université de Paris, Paris, France.

Muriel Picard (M)

Service de Réanimation Polyvalente, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

Djamel Mokart (D)

Critical Care Department, Institut Paoli Calmettes, Marseille, France.

Laure Calvet (L)

Service de Reanimation Medicale, Hopital Gabriel Monpied, CHU, Clermont-Ferrand, France.

Fabrice Bruneel (F)

Intensive Care Unit, André Mignot Hospital, Le Chesnay, France.

Etienne de Montmollin (E)

Medical and infectious diseases ICU, AP-HP, Bichat-Claude Bernard Hospital, Paris Cedex, France.

Nadia Aissaoui (N)

Medical Intensive Care Unit, European Hospital Georges-Pompidou, Sorbonne Paris Cité, Paris Descartes University, Paris, France.

Benoit Champigneulle (B)

Anaesthesiology and Intensive Care Department, European Hospital Georges-Pompidou, Paris, France.

Naike Bigé (N)

Service de Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.

Florence Boissier (F)

CHU de Poitiers, Service de Médecine Intensive Réanimation, INSERM CIC 1402 (ALIVE group), Université de Poitiers, Poitiers, France.

Frédéric Pène (F)

AP-HP, Hôpital Cochin, Service de Médecine Intensive et Réanimation, CNRS UMR8104, INSERM U1016AP-HP, Université de Paris, Paris, France.

Julien Mayaux (J)

Intensive Care Unit, AP-HP, Pitié-Salpétrière Hospital, Paris University, Paris, France.

Laurent Argaud (L)

Medical ICU, Edouard Herriot University Hospital, Lyon, France.

Anne Sophie Moreau (AS)

Department of Intensive Care, CHU Lille, Lille, France.

Martin Murgier (M)

Medical-surgical Intensive care unit, Saint-Etienne University Hospital, Saint Etienne, France.

Elie Azoulay (E)

AP-HP, Hôpital Saint-Louis, Medical ICU, Université de Paris, Paris, France.

Michael Darmon (M)

AP-HP, Hôpital Saint-Louis, Medical ICU, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH